Teva gets approval to buy Bentley

Teva Pharmaceutical Industries received nearly a 69 percent shareholder approval to complete its $360 million dollar purchase of Bentley Pharmaceuticals, a move the company hopes will help it to expand sales in Spain with over 170 products. Report.